xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

439

ICAR SINONASAL TUMORS

rent nasopharyngeal carcinoma at the primary site. Laryn goscope . 2005;115(8):1517-1519. https://doi.org/10.1097/01.Mlg. 0000165383.35100.17 1664. Castelnuovo P, Nicolai P, Turri-Zanoni M, et al. Endoscopic endonasal nasopharyngectomy in selected cancers. Otolaryn gol Head Neck Surg . 2013;149(3):424-430. https://doi.org/10. 1177/0194599813493073 1665. Liu Q, Sun X, Li H, et al. Types of transnasal endo scopic nasopharyngectomy for recurrent nasopharyngeal car cinoma: Shanghai EENT hospital experience. Front Oncol . 2020;10:555862. https://doi.org/10.3389/fonc.2020.555862 1666. Zou X, Han F, Ma WJ, et al. Salvage endoscopic nasopharyn gectomy and intensity-modulated radiotherapy versus con ventional radiotherapy in treating locally recurrent nasopha ryngeal carcinoma. Head Neck . 2015;37(8):1108-1115. https:// doi.org/10.1002/hed.23719 1667. Yang J, Song X, Sun X, et al. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis. Int Forum Allergy Rhi nol . 2020;10(8):1001-1011. https://doi.org/10.1002/alr.22552 1668. Liu YP, Wen YH, Tang J, et al. Endoscopic surgery com pared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol . 2021;22(3):381-390. https://doi.org/10.1016/s1470 2045(20)30673-2 1669. Eberhard TP, Leaming RH. Treatment of carcinoma of the nasopharynx by irradiation. Radiology . 1950;55(1):46-51. https://doi.org/10.1148/55.1.46 1670. Peng G, Wang T, Yang KY, et al. A prospective, random ized study comparing outcomes and toxicities of intensity modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol . 2012;104(3):286-293. https://doi.org/10.1016/ j.radonc.2012.08.013 1671. Co J, Mejia MB, Dizon JM. Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: meta-analysis and a systematic review of the literature. Head Neck . 2016;38(Suppl 1):E2130-E2142. https://doi.org/10.1002/ hed.23977 1672. Du T, Xiao J, Qiu Z, Wu K. The effectiveness of intensity modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: a systematic review and meta analysis. PLoS ONE . 2019;14(7):e0219611. https://doi.org/10. 1371/journal.pone.0219611 1673. Huang CL, Xu C, Zhang Y, et al. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2,521 patients. Radiat Oncol . 2018;13(1):141. https://doi.org/10.1186/s13014-018-1087-x 1674. Tang LL, Huang CL, Zhang N, et al. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial. Lancet Oncol . 2022;23(4):479-490. https://doi.org/10.1016/S1470 2045(22)00058-4 1675. Figen M, Colpan Oksuz D, Duman E, et al. Radiotherapy for head and neck cancer: evaluation of triggered adaptive replan-

Front Oncol . 2021;11:688615. https://doi.org/10.3389/fonc.2021. 688615 1650. Verma V, Simone CB, Lin C. Human papillomavirus and nasopharyngeal cancer. Head Neck . 2018;40(4):696-706. https://doi.org/10.1002/hed.24978 1651. Huang SH, Jacinto JCK, O’Sullivan B, et al. Clinical presenta tion and outcome of human papillomavirus-positive nasopha ryngeal carcinoma in a North American cohort. Cancer . 2022;128(15):2908-2921. https://doi.org/10.1002/cncr.34266 1652. Wu SS, Chen B, Fleming CW, et al. Nasopharyngeal can cer: incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution. HeadNeck . 2022;44(4):851-861. https://doi.org/10. 1002/hed.26976 1653. Simon J, Schroeder L, Ingarfield K, et al. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic coun try. Int J Cancer . 2020;147(2):461-471. https://doi.org/10.1002/ ijc.33006 1654. Verma N, Patel S, Osborn V, et al. Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyn geal carcinoma. HeadNeck . 2020;42(9):2364-2374. https://doi. org/10.1002/hed.26245 1655. Wotman M, Oh EJ, Ahn S, Kraus D, Costantino P, Tham T. HPV status in patients with nasopharyngeal carcinoma in the United States: a SEER database study. Am J Otolaryn gol . 2019;40(5):705-710. https://doi.org/10.1016/j.amjoto.2019. 06.007 1656. Huang CC, Hsiao JR, Yang MW, et al. Human papilloma virus detection in neoplastic and non-neoplastic nasopharyngeal tissues in Taiwan. J Clin Pathol . 2011;64(7):571-577. https://doi. org/10.1136/jcp.2010.087742 1657. Huang WB, Chan JYW, Liu DL. Human papillomavirus and World Health Organization type III nasopharyngeal carci noma: multicenter study from an endemic area in Southern China. Cancer . 2018;124(3):530-536. https://doi.org/10.1002/ cncr.31031 1658. Blanchard P, Lee A, Marguet S, et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol . 2015;16(6):645-655. https://doi.org/10.1016/s1470-2045(15)70126-9 1659. Wei WI, Lam KH, Sham JS. New approach to the nasophar ynx: the maxillary swing approach. HeadNeck . 1991;13(3):200 207. https://doi.org/10.1002/hed.2880130306 1660. Tu GY, Hu YH, Xu GZ, Ye M. Salvage surgery for nasopha ryngeal carcinoma. Arch Otolaryngol Head Neck Surg . 1988;114(3):328-329. https://doi.org/10.1001/archotol.1988. 01860150110026 1661. Morton RP, Liavaag PG, McLean M, Freeman JL. Transcervico-mandibulo-palatal approach for surgi cal salvage of recurrent nasopharyngeal cancer. Head Neck . 1996;18(4):352-358. https://doi.org/10.1002/(sici)1097 0347(199607/08)18:4 ⟨ 352::Aid-hed7 ⟩ 3.0.Co;2-x 1662. Wang WH, Yeh CF, Lan MY. The role of nasopharyngectomy in the management of nasopharyngeal carcinoma. CurrOpin Otolaryngol Head Neck Surg . 2022;30(1):3-12. https://doi.org/ 10.1097/moo.0000000000000780 1663. Yoshizaki T, Wakisaka N, Murono S, Shimizu Y, Furukawa M. Endoscopic nasopharyngectomy for patients with recur